So once again they blame the shareholders. I long for the days when Medify cared about the shareholders like JB did:
Jonathan Bryant, Executive Chairman, said: "It is a very exciting time for the management of all Medify Businesses, our customers and especially our shareholders. The planned float will not only strengthen our position but will introduce financial support into subsidiaries to enable us to accelerate our plans under our own steam with dedicated team specifically charged to deliver in each country. From a shareholder perspective, for each and every share held on the day before the public float, they will receive, at no cost, the same number of free trading stock in the International floated company."
"Best for our customers, stability and success for the company and reward for our supporting team of shareholders."
OH, wait a minute...
